Latest Pharmaceutical sciences Stories

“Generic and innovative drugs market in CIS countries 2013. Russia, Ukraine and Kazakhstan” is the new market research report added to ReportsnReports.com store. Dallas, TX (PRWEB) May 09, 2013 Keep current with the changing CIS generic and innovative drug segments. Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015. Generic and innovative drug segments in CIS countries have played a huge role in supporting the pharmaceutical industry. Meanwhile,...

FRISCO, Texas, May 9, 2013 /PRNewswire/ -- Assured Pharmacy (APHY:OTC Markets), a leading pharmacy group that specializes in providing prescription medications to sufferers of chronic pain, today announced plans to open two additional new stores in Denver and Boston this summer as part of a major expansion strategy. Like all Assured Pharmacy stores, the new stores will operate on a compliance-based model to ensure strict control over the safe dispensing and delivery of controlled...

[WATCH VIDEO: Caffeine In Food Investigated By FDA] Michael Harper for redOrbit.com – Your Universe Online For whatever reason, food and drink makers have been actively pursuing ways to put caffeine into otherwise caffeine-free products including Cracker Jacks, potato chips and chewing gum. Wrigley, for instance, recently launched Alert Energy Caffeine Gum which contains 40 milligrams of caffeine — about as much as a half cup of coffee — in each piece. Meanwhile the FDA and...

Emmaus in Process of Completing Phase 3 Study For First Widely Available Treatment for Sickle Cell Disease TORRANCE, Calif., May 9, 2013 /PRNewswire/ -- Timothy Cote, M.D., MPH, former director of the Office of Orphan Product Development of the U.S. Food and Drug Administration, has joined Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, in an advisory capacity, the company announced today. Dr. Cote will advise Emmaus on the regulatory pathway for...

Health & Life Co., LTD. Issues Nationwide Recall of EZ Breathe(TM) Atomizer, Model #EZ-100 NEW TAIPEI CITY, Taiwan, May 8, 2013 /PRNewswire/ -- Recall Managed By: Nephron Pharmaceuticals Corporation Health & Life Co., LTD 9F, No. 186, Jian Yi Road Zhonge District 23553 New Taipei City, Taiwan 886.2.82271300 www.healthandlife.com.tw On May 8, 2013, Health & Life, Co., LTD, initiated a nationwide recall of 242,892 EZ Breathe(TM) Atomizers, Model #EZ-100, after...

WASHINGTON, May 8, 2013 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts today applauded Senators Kirsten Gillibrand (D-NY), Dianne Feinstein (D-CA), and Susan Collins (R-ME), for introducing the Antimicrobial Data Collection Act, which would require the U.S. Food and Drug Administration, or FDA, to report more information on the annual sales of antibiotics used among industrial farm animals. The bipartisan bill would also give the agency a deadline to finalize policies proposed last...

WOODCLIFF LAKE, N.J., May 8, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, May 16, 2013, at 10:00 a.m. EDT to review its results of operations for the quarter ended March 31, 2013. Par is privately held and does not generally make its financial information available to the public. However, holders of Par's debt securities, certain prospective holders of Par's debt securities and research analysts who cover or...

CRANBURY, N.J., May 8, 2013 /PRNewswire/ -- Oncobiologics, Inc. announced today that Zhejiang Huahai Pharmaceutical Co., Ltd and Oncobiologics have signed an alliance agreement for the development, manufacture and commercialization of biosimilar monoclonal antibody products. The scope of the agreement includes exclusive commercialization by Huahai of four biosimilars developed by Oncobiologics and manufactured in China at a Huahai biologics facility for the China market, and will...

Company Confirms Cancellation of 1 Billion Shares, Continuing Efforts to Cancel Additional 5 Billion Shares and OTC Marketplace Update SAN GERONIMO, Calif., May 8, 2013 /PRNewswire/ -- Virogen Inc. (OTC:VRNI), a holding company that owns Tiger Team Technologies and The Cannabis Connection, today advised of its progress following recent announcements concerning its new business unit, The Cannabis Connection, a company initiative designed to capture a portion of the $15-20 billion...

Drug manufacturer Merck recently sought and earned U.S. Food and Drug Administration approval for a new drug that pairs its own cholesterol-lowering Zetia with a generic version of Lipitor, the blockbuster statin marketed by Pfizer before it lost patent protection in 2011. The Rottenstein Law Group, which represents clients in Lipitor lawsuits, is watching this development closely, noting that studies have established a link between Lipitor and Type 2 diabetes. (PRWEB) May 07, 2013 Drug...